Table 2.

Comparison of development of CFT and BCVA of the Ranibizumab and the Aflibercept group after the loading dose and after 1 year, respectively

	Ranibizumab (16 eyes)	Aflibercept (11 eyes)	Difference	Confidence interval	p-value
Loading phase
Change of Letters after loading dose(mean ± SD)	13.81 ± 20.48	6.36 ± 15.46	7.45	−7.58 to 22.48	0.317
Change of CFT after loading dose (mean ± SD) [μm]	−169.06 ± 140.60	−84.73 ± 143.65	−84.34	−198.74 to 30.07	0.142
1 year
Change of Letters after 1 year (mean ± SD)	15.00 ± 21.77	5.64 ± 12.64	9.36	−5.69 to 24.41	0.212
Change of CFT after 1 year (mean ± SD) [μm]	−155.50 ± 160.14	78.45 ± 165.83	−77.05	−208.08 to 53.99	0.237